Daily9 天
Danicopan therapy with eculizumab or ravulizumab may reduce breakthrough hemolysis events ...
Researchers have discovered that with the dual inhibition of C5 and factor D, patients with paroxysmal nocturnal ...
Nature4 年
Methods of Diagnosing and Treating CHAPLE, A Newly Identified Orphan Disease: Collaborative ...
Recent off-label use of a complement inhibiting drug, eculizumab (CD55 inhibitor) was shown to provide a dramatic benefit in patients with CHAPLE disease with an immediate correction of ...